Table 3 Lung function and prevalence of ACO in cohorts of SAAS and COREA

 FEV₁ L post BD

3.34 (2.90–4.17)

2.87 (2.40–3.36) ^a

2.01 (1.75–2.50) ^a,b

 FEV₁% pred post BD

90 (84–100)

86 (74–99)

79 (60–89) ^a,b

 FEV₁/FVC post BD

0.81 (0.75–0.87)

0.78 (0.73–0.83) ^a

0.73 (0.62–0.79) ^a,b

 FVC % pred post BD

95 (88–103)

92 (78–103)

87 (73–98) ^a

 DLco % predicted^c

100 ± 20

95 ± 19

92 ± 18

 DL/VA % predicted^c

104 ± 19

98 ± 19

97 ± 15

 ACO^d

3 (3.7%)

11 (9.7%)

10 (22.2%) ^a

 FEV₁ L post BD

2.74 ± 0.90

2.23 ± 0.69 ^a

1.70 ± 0.57 ^a,b

 FEV₁% pred post BD

84 ± 21

82 ± 23

75 ± 24 ^a,b

 FEV₁/FVC post BD

0.77 ± 0.13

0.72 ± 0.13 ^a

0.66 ± 0.15 ^a,b

 FVC% pred post BD

90 ± 16

90 ± 17

84 ± 21 ^a,b

 ACO^d

17 (6.9%)

55 (17.4%)

82 (36.6%)